A detailed history of Bayesian Capital Management, LP transactions in Hologic Inc stock. As of the latest transaction made, Bayesian Capital Management, LP holds 7,889 shares of HOLX stock, worth $573,372. This represents 0.08% of its overall portfolio holdings.

Number of Shares
7,889
Previous 23,034 65.75%
Holding current value
$573,372
Previous $1.71 Million 62.46%
% of portfolio
0.08%
Previous 0.2%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$73.48 - $83.64 $1.11 Million - $1.27 Million
-15,145 Reduced 65.75%
7,889 $642,000
Q2 2024

Aug 14, 2024

BUY
$71.43 - $78.41 $1.65 Million - $1.81 Million
23,034 New
23,034 $1.71 Million
Q4 2023

Feb 14, 2024

BUY
$65.11 - $72.63 $4.36 Million - $4.87 Million
67,034 New
67,034 $4.79 Million
Q4 2022

Feb 14, 2023

BUY
$61.6 - $76.99 $954,800 - $1.19 Million
15,500 New
15,500 $1.16 Million
Q4 2021

Feb 14, 2022

SELL
$68.97 - $77.92 $365,541 - $412,976
-5,300 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$67.56 - $80.74 $358,068 - $427,922
5,300 New
5,300 $391,000
Q2 2021

Aug 13, 2021

SELL
$60.52 - $76.68 $817,806 - $1.04 Million
-13,513 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$68.76 - $83.72 $1.18 Million - $1.44 Million
-17,200 Reduced 56.0%
13,513 $1.01 Million
Q4 2020

Feb 12, 2021

BUY
$65.85 - $76.67 $2.02 Million - $2.35 Million
30,713 New
30,713 $2.24 Million
Q1 2020

May 15, 2020

SELL
$29.38 - $54.65 $123,396 - $229,530
-4,200 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$45.61 - $53.56 $191,562 - $224,952
4,200 New
4,200 $219,000
Q1 2019

May 14, 2019

SELL
$38.28 - $48.4 $405,768 - $513,040
-10,600 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$37.76 - $44.89 $400,256 - $475,834
10,600 New
10,600 $436,000

Others Institutions Holding HOLX

About HOLOGIC INC


  • Ticker HOLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 249,652,992
  • Market Cap $18.1B
  • Description
  • Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The...
More about HOLX
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.